Viropro Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 34

Employees

  • Stock Symbol
  • VPRO

Stock Symbol

  • Investments
  • 3

Viropro General Information

Description

Viropro Inc is an integrated developer and manufacturer of biopharmaceutical products that address unmet medical needs efficiently and cost-effectively. The company intends to develop its products for commercial sale and make its facility available for contract manufacturing.

Contact Information

Website
www.viropro.net
Formerly Known As
Food Concepts
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 4199 Campus Drive
  • Office of Technology Alliances, Suite 550
  • Irvine, CA 92612
  • United States
+1 (949)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 4199 Campus Drive
  • Office of Technology Alliances, Suite 550
  • Irvine, CA 92612
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viropro Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
850.00

Viropro Financials Summary

As of 30-Sep-2011, Viropro has a trailing 12-month revenue of $1.01M.

In Thousands,
USD
TTM 30-Sep-2011 FY 2010 31-Dec-2010 FY 2009 30-Nov-2009 FY 2008 30-Nov-2008
EV 26,828 958 3,512 1,430
Revenue 1,013 571 0 0
Net Income (2,253) (1,010) (1,465) (1,735)
Total Assets 38,774 2,114 62 130
Total Debt 12,049 176 100 1,178
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Viropro Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Viropro‘s full profile, request access.

Request a free trial

Viropro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viropro Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Viropro‘s full profile, request access.

Request a free trial

Viropro Acquisitions (3)

Viropro’s most recent deal was a Merger/Acquisition with Activate Immunotherapy. The deal was made on 02-May-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Activate Immunotherapy 02-May-2016 Merger/Acquisition Drug Discovery
Alpha Biologics 22-Feb-2011 Merger/Acquisition Other Healthcare Services
Biologics Process Development 14-Apr-2010 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Viropro’s complete acquisitions history, request access »

Viropro FAQs

  • When was Viropro founded?

    Viropro was founded in 1997.

  • Where is Viropro headquartered?

    Viropro is headquartered in Irvine, CA.

  • What is the size of Viropro?

    Viropro has 34 total employees.

  • What industry is Viropro in?

    Viropro’s primary industry is Drug Discovery.

  • Is Viropro a private or public company?

    Viropro is a Public company.

  • What is Viropro’s stock symbol?

    The ticker symbol for Viropro is VPRO.

  • What is Viropro’s current revenue?

    The trailing twelve month revenue for Viropro is $1.01M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process